Similar articles for PMID: 27905127

Year	Number of Results
1948	1
1981	1
1983	1
1985	1
1987	1
1989	2
1990	2
1991	1
1993	1
1994	1
1996	2
1997	1
1998	1
1999	2
2000	4
2001	1
2002	3
2003	1
2004	2
2005	4
2006	3
2007	1
2008	1
2009	4
2011	1
2013	3
2014	4
2015	6
2016	8
2017	6
2018	3
2019	3
2020	4
2021	1
2022	2
2023	2
2024	0

1

Reply letter to "ADCY5-related dyskinesia: Comments on characteristic manifestations and variant-associated severity".

Fung VS, Chang FC, Westenberger A, Klein C. Fung VS, et al. Mov Disord. 2017 Feb;32(2):306. doi: 10.1002/mds.26881. Epub 2016 Dec 1. Mov Disord. 2017. PMID: 27905127 No abstract available.

2

ADCY5-related dyskinesia: Comments on characteristic manifestations and variant-associated severity.

Raskind WH, Friedman JR, Roze E, Méneret A, Chen DH, Bird TD. Raskind WH, et al. Mov Disord. 2017 Feb;32(2):305-306. doi: 10.1002/mds.26888. Epub 2016 Dec 9. Mov Disord. 2017. PMID: 27933653 Free PMC article. No abstract available.

3

[Dyskinesia caused by L-DOPA].

Derkinderen P, Vidailhet M. Derkinderen P, et al. Rev Neurol (Paris). 2002 Dec;158 Spec no 1:S92-101. Rev Neurol (Paris). 2002. PMID: 12690668 Review. French.

4

Hyperphosphorylated Tau, Increased Adenylate Cyclase 5 (ADCY5) Immunoreactivity, but No Neuronal Loss in ADCY5-Dyskinesia.

Chen DH, Latimer CS, Spencer M, Karna P, Gonzalez-Cuyar LF, Davis MY, Keene CD, Bird TD, Raskind WH. Chen DH, et al. Mov Disord Clin Pract. 2019 Dec 14;7(1):70-77. doi: 10.1002/mdc3.12873. eCollection 2020 Jan. Mov Disord Clin Pract. 2019. PMID: 31970214 Free PMC article.

5

Effects of theophylline on ADCY5 activation-From cellular studies to improved therapeutic options for ADCY5-related dyskinesia patients.

Tänzler D, Kipping M, Lederer M, Günther WF, Arlt C, Hüttelmaier S, Merkenschlager A, Sinz A. Tänzler D, et al. PLoS One. 2023 Mar 3;18(3):e0282593. doi: 10.1371/journal.pone.0282593. eCollection 2023. PLoS One. 2023. PMID: 36867608 Free PMC article.

6

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.

Svenningsson P, Rosenblad C, Af Edholm Arvidsson K, Wictorin K, Keywood C, Shankar B, Lowe DA, Björklund A, Widner H. Svenningsson P, et al. Brain. 2015 Apr;138(Pt 4):963-73. doi: 10.1093/brain/awu409. Epub 2015 Feb 10. Brain. 2015. PMID: 25669730 Free PMC article. Clinical Trial.

7

[Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].

Maurel F, Lilliu H, Le Pen C. Maurel F, et al. Rev Neurol (Paris). 2001 May;157(5):507-14. Rev Neurol (Paris). 2001. PMID: 11438770 French.

8

Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.

Herz DM, Haagensen BN, Nielsen SH, Madsen KH, Løkkegaard A, Siebner HR. Herz DM, et al. Mov Disord. 2016 Apr;31(4):521-9. doi: 10.1002/mds.26540. Epub 2016 Mar 8. Mov Disord. 2016. PMID: 26954295 Free PMC article.

9

ADCY5-Related Dyskinesia in a Child with Sleep Related Paroxysmal Dyskinesia.

Holla VV, Neeraja K, Prasad S, Kamble N, Pal PK. Holla VV, et al. Indian J Pediatr. 2021 Mar;88(3):308-309. doi: 10.1007/s12098-020-03536-0. Epub 2020 Oct 14. Indian J Pediatr. 2021. PMID: 33051786 No abstract available.

10

Punding and dyskinesias.

Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Silveira-Moriyama L, et al. Mov Disord. 2006 Dec;21(12):2214-7. doi: 10.1002/mds.21118. Mov Disord. 2006. PMID: 17013916

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

72 results

Results by year